サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1743803

動物用ワクチン市場-世界の産業規模、シェア、動向、機会、予測、ワクチンタイプ別、技術別、地域別、競合別、2020-2030年

Veterinary Vaccines Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type, By Technology, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

動物用ワクチン市場-世界の産業規模、シェア、動向、機会、予測、ワクチンタイプ別、技術別、地域別、競合別、2020-2030年
出版日: 2025年06月06日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物用ワクチンの世界市場規模は、2024年に84億4,000万米ドルとなり、2030年までCAGR 7.28％で成長すると予測されています。

同市場は、コンパニオンアニマルおよび家畜の病気を予防・管理するために設計されたワクチンを提供することで、獣医ヘルスケアにおいて重要な役割を果たしています。これらのワクチンは、動物の健康を確保し、食糧安全保障を維持し、人獣共通感染症の感染リスクを低減するために不可欠です。倫理的で持続可能な動物用医薬品に対する需要の高まりは、ワクチン技術の進歩や新興疾患に対するプラットフォームベースのソリューションの台頭と相まって、市場拡大に寄与しています。欧州医薬品庁がトルコヘルペスウイルスベクタープラットフォームであるInnovax vPTMFを認証したようなイノベーションは、迅速な対応とワクチン入手のしやすさの向上に対する業界のコミットメントを示しています。動物の健康に対する意識が高まり続ける中、動物用ワクチン市場は世界的に力強い成長が見込まれています。

市場概要
予測期間 2026-2030
市場規模：2024年 84億4,000万米ドル
市場規模：2030年 127億6,000万米ドル
CAGR：2025年～2030年 7.28%
急成長セグメント 生ワクチン
最大市場 北米

市場促進要因

動物福祉に対する意識の高まり

主な市場課題

規制上のハードルと承認プロセス

主な市場動向

予防ヘルスケアへの注目の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場促進要因、課題、動向の概要

第5章 顧客の声

第6章 世界の動物用ワクチン市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • ワクチンの種類別（家畜ワクチン、コンパニオンアニマルワクチン）
    • 技術別（生弱毒化ワクチン、不活化ワクチン、トキソイドワクチン、組み換えワクチン、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第7章 北米の動物用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州の動物用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン

第9章 アジア太平洋地域の動物用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米の動物用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの動物用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第14章 世界の動物用ワクチン市場：SWOT分析

第15章 競合情勢

  • Zoetis Inc.
  • Merck & Co. Inc.
  • Virbac
  • Hester Biosciences Limited
  • Elanco Animal Health
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Phibro Animal Health Corporation
  • HIPRA

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 16220

The Global Veterinary Vaccines Market was valued at USD 8.44 billion in 2024 and is projected to grow at a CAGR of 7.28% through 2030. This market plays a critical role in veterinary healthcare by providing vaccines designed to prevent and manage diseases in both companion animals and livestock. These vaccines are essential for ensuring animal health, maintaining food security, and reducing the risk of zoonotic disease transmission. Growing demand for ethical and sustainable animal products, coupled with advancements in vaccine technology and the rise of platform-based solutions for emerging diseases, are contributing to market expansion. Innovations like the European Medicines Agency's certification of the Innovax vPTMF, a turkey herpesvirus vector platform, demonstrate the industry's commitment to rapid response and improved vaccine accessibility. As awareness around animal health continues to rise, the veterinary vaccines market is poised for strong growth globally.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 8.44 Billion
Market Size 2030USD 12.76 Billion
CAGR 2025-20307.28%
Fastest Growing SegmentLive Attenuated Vaccine
Largest MarketNorth America

Key Market Drivers

Growing Awareness of Animal Welfare

Increasing public awareness regarding animal welfare is a key factor driving the veterinary vaccines market. Pet owners are more invested in the health of their animals, prioritizing routine vaccinations to extend the life and quality of their pets. Similarly, in livestock farming, the focus on humane treatment and productivity has prompted producers to adopt preventive healthcare strategies, including vaccination. Ethical consumerism is shaping market demand, as buyers prefer products sourced from healthy and well-treated animals. Regulatory frameworks and animal welfare certifications now often include vaccine requirements as part of disease prevention protocols. A notable development is the European Medicines Agency's 2024 certification of the Innovax vPTMF vaccine platform, which enables rapid customization of vaccines to address emerging threats, bolstering preparedness and public health resilience.

Key Market Challenges

Regulatory Hurdles and Approval Processes

The veterinary vaccines market is significantly impacted by the complex and varying regulatory standards across global regions. Navigating country-specific approval processes presents a substantial challenge for manufacturers, often leading to high compliance costs and extended timelines. Regulatory agencies demand rigorous safety and efficacy evaluations, including detailed preclinical and clinical testing. These requirements, while essential for public and animal health, add layers of complexity that slow down time-to-market for new vaccines. Delays in vaccine registration further hinder growth, especially for companies looking to respond swiftly to evolving disease patterns.

Key Market Trends

Increasing Focus on Preventive Healthcare

An emerging trend across the veterinary landscape is the heightened emphasis on preventive care through vaccination. Both pet owners and livestock producers are increasingly aware of the benefits of immunization in minimizing disease outbreaks, reducing treatment costs, and enhancing animal welfare. Preventive healthcare is now viewed as a strategic investment, particularly in the companion animal sector where routine vaccinations are standard. In livestock operations, preventive vaccination supports herd health and productivity, reducing economic losses linked to illness. This trend is reshaping the approach to animal care, prioritizing early intervention and long-term health maintenance.

Key Market Players

  • Zoetis Inc.
  • Merck & Co. Inc.
  • Virbac SA
  • Hester Biosciences Limited
  • Elanco Animal Health
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Phibro Animal Health Corporation
  • HIPRA

Report Scope:

In this report, the Global Veterinary Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Vaccines Market, By Vaccine Type:

  • Livestock Vaccine
  • Companion Animal Vaccine

Veterinary Vaccines Market, By Technology:

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Other

Veterinary Vaccines Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Vaccines Market.

Available Customizations:

Global Veterinary Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries

4. Overview of Market Drivers, Challenges, Trends

5. Voice of Customer

6. Global Veterinary Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Vaccine Type (Livestock Vaccine, Companion Animal Vaccine)
    • 6.2.2. By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other)
    • 6.2.3. By Region
    • 6.2.4. By Company (2024)
  • 6.3. Market Map

7. North America Veterinary Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Vaccine Type
    • 7.2.2. By Technology
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Veterinary Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Vaccine Type
        • 7.3.1.2.2. By Technology
    • 7.3.2. Canada Veterinary Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Vaccine Type
        • 7.3.2.2.2. By Technology
    • 7.3.3. Mexico Veterinary Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Vaccine Type
        • 7.3.3.2.2. By Technology

8. Europe Veterinary Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Vaccine Type
    • 8.2.2. By Technology
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Veterinary Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Vaccine Type
        • 8.3.1.2.2. By Technology
    • 8.3.2. United Kingdom Veterinary Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Vaccine Type
        • 8.3.2.2.2. By Technology
    • 8.3.3. Italy Veterinary Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecasty
        • 8.3.3.2.1. By Vaccine Type
        • 8.3.3.2.2. By Technology
    • 8.3.4. France Veterinary Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Vaccine Type
        • 8.3.4.2.2. By Technology
    • 8.3.5. Spain Veterinary Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Vaccine Type
        • 8.3.5.2.2. By Technology

9. Asia-Pacific Veterinary Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Vaccine Type
    • 9.2.2. By Technology
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Veterinary Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Vaccine Type
        • 9.3.1.2.2. By Technology
    • 9.3.2. India Veterinary Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Vaccine Type
        • 9.3.2.2.2. By Technology
    • 9.3.3. Japan Veterinary Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Vaccine Type
        • 9.3.3.2.2. By Technology
    • 9.3.4. South Korea Veterinary Vaccines Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Vaccine Type
        • 9.3.4.2.2. By Technology
    • 9.3.5. Australia Veterinary Vaccines Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Vaccine Type
        • 9.3.5.2.2. By Technology

10. South America Veterinary Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Vaccine Type
    • 10.2.2. By Technology
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Vaccine Type
        • 10.3.1.2.2. By Technology
    • 10.3.2. Argentina Veterinary Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Vaccine Type
        • 10.3.2.2.2. By Technology
    • 10.3.3. Colombia Veterinary Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Vaccine Type
        • 10.3.3.2.2. By Technology

11. Middle East and Africa Veterinary Vaccines Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Vaccine Type
    • 11.2.2. By Technology
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Veterinary Vaccines Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Vaccine Type
        • 11.3.1.2.2. By Technology
    • 11.3.2. Saudi Arabia Veterinary Vaccines Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Vaccine Type
        • 11.3.2.2.2. By Technology
    • 11.3.3. UAE Veterinary Vaccines Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Vaccine Type
        • 11.3.3.2.2. By Technology

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Product Launches
  • 13.3. Mergers & Acquisitions

14. Global Veterinary Vaccines Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Zoetis Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Technology Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck & Co. Inc.
  • 15.3. Virbac
  • 15.4. Hester Biosciences Limited
  • 15.5. Elanco Animal Health
  • 15.6. Boehringer Ingelheim International GmbH
  • 15.7. Ceva Sante Animale
  • 15.8. Phibro Animal Health Corporation
  • 15.9. HIPRA

16. Strategic Recommendations

17. About Us & Disclaimer